Decipher Labs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE643N01012
  • NSEID:
  • BSEID: 524752
INR
5.89
0.2 (3.51%)
BSENSE

Oct 09

BSE+NSE Vol: 2.03 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Brawn Biotech
Vivanza Biosci.
Decipher Labs
Solara Active PP
Ortin Global
Dipna Pharmachem
Genomic Valley
Ganga Pharma.
Fabino Enter
Shyama Computro.
Triochem Product
Why is Decipher Labs Ltd ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -3.17
  • The company has been able to generate a Return on Capital Employed (avg) of 5.19% signifying low profitability per unit of total capital (equity and debt)
2
The company has declared Negative results for the last 6 consecutive quarters
  • NET SALES(Latest six months) At Rs 7.52 cr has Grown at -35.56%
  • PAT(Latest six months) At Rs -0.52 cr has Grown at -35.56%
  • CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 0.80 cr
3
Stock is technically in a Mildly Bearish range
  • The stocks Bollinger Band and KST technical factors are also Bearish
4
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -41.50%, its profits have fallen by -829%
5
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -41.50% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Decipher Labs for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Decipher Labs
-40.32%
-0.67
61.89%
Sensex
-11.8%
-0.49
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-24.39%
EBIT Growth (5y)
-198.04%
EBIT to Interest (avg)
-3.99
Debt to EBITDA (avg)
0.85
Net Debt to Equity (avg)
-0.01
Sales to Capital Employed (avg)
1.48
Tax Ratio
25.31%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
-20.35%
ROE (avg)
9.42%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
36
Price to Book Value
0.29
EV to EBIT
-2.05
EV to EBITDA
-2.55
EV to Capital Employed
0.28
EV to Sales
0.42
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-19.24%
ROE (Latest)
-20.85%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-5What is not working for the Company
NET SALES(9M)

At Rs 9.22 cr has Grown at -24.55%

PAT(9M)

At Rs -3.09 cr has Grown at -24.55%

CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 0.74 cr

Loading Valuation Snapshot...
Here's what is not working for Decipher Labs
Net Sales - Nine Monthly
At Rs 9.22 cr has Grown at -24.55%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Profit After Tax (PAT) - Nine Monthly
At Rs -3.09 cr has Grown at -24.55%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is negative

PAT (Rs Cr)

Cash and Cash Equivalents - Half Yearly
Lowest at Rs 0.74 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents